🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall objective is to evaluate the safety and efficacy of teprotumuma...
Status
Completed
Location
Macro, Llc
Start Date
2018-04-16
Trial ID
NCT03461211
Treatments Being Tested
Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune dis...
Status
Recruiting
Location
Shanghai Changzheng Hospital
Start Date
2025-04-10
Trial ID
NCT07152340
Treatments Being Tested
The primary objective of this trial are to assess the pharmacokinetics (PK)...
Status
Completed
Location
PPD Development, LP
Start Date
2023-03-24
Trial ID
NCT06674941
Treatments Being Tested
LASN01 is a novel, fully human antibody directed against the human IL-11 re...
Status
Completed
Location
Site 111
Start Date
2024-03-05
Trial ID
NCT06226545
A multicenter clinical study to evaluate the efficacy and safety of IBI311 ...
Status
Recruiting
Location
The First Affiliated Hospital of Medical University
Start Date
2025-09-10
Trial ID
NCT07113262
This study aims to evaluate the efficacy and safety of sequential Teprotumu...
Status
Not Yet Recruiting
Location
Zhongshan Ophthalmic Center, Sun Yat-sen University
Start Date
2026-08
Trial ID
NCT07594912
Treatments Being Tested
The overall objective is to investigate the safety, tolerability and effect...
Status
Terminated
Location
UCLA Division of Rheumatology
Start Date
2021-11-17
Trial ID
NCT04478994
The overall objective is to investigate the efficacy, tolerability, and saf...
Status
Completed
Location
Macro, Llc
Start Date
2017-10-04
Trial ID
NCT03298867
Treatments Being Tested
This is an expanded access protocol intended to provide access to teprotumu...
Status
Approved For Marketing
Location
MACRO Trials
Start Date
TBD
Trial ID
NCT04040894
Treatments Being Tested